|
⚲
|
| Lixte Biotechnology Holdings Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001335105 |
| Sale | 2010-01-20 ($1.8 M Offered, $1.8 M Sold) |
| Fund | |
| Phone | 6319427959 |
| Address | 248 Route 25A East Setauket, 11733 |
| Source | [EDGAR] |
| Fund AUM and Sold ($k) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Stephen Carter | |
| Philip Palmedo | |
| Mel Sorenson | |
| John Kovach |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
COLO Holdings, LLC
✚
|
0.0 | |
|
Nanuet Holdings, LLC
✚
|
0.0 | |
|
Nan Zhengfu
✚
|
0.0 | |
|
Narayanan Mahesh
✚
|
0.0 | |
|
Colon Angel
✚
|
0.0 | |
|
Nardi Thomas A
✚
|
0.0 | |
|
Colonial House Capital Ltd
✚
|
0.0 | |
|
NAS Acquisition Inc
✚
|
0.0 | |
|
National CCRC Statutory Tier IV Trust
✚
|
0.0 | |
|
AU Fund II, a series of MV Funds, LP
✚
|
0.0 |